Rosenkranz S - Search Results

1

Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation.

ten Freyhaus H, Huntgeburth M, Wingler K, Schnitker J, Bäumer AT, Vantler M, Bekhite MM, Wartenberg M, Sauer H, Rosenkranz S. ten Freyhaus H, et al. Among authors: rosenkranz s. Cardiovasc Res. 2006 Jul 15;71(2):331-41. doi: 10.1016/j.cardiores.2006.01.022. Epub 2006 Mar 20. Cardiovasc Res. 2006. PMID: 16545786

2

Inhibition of the PDGF receptor by red wine flavonoids provides a molecular explanation for the "French paradox".

Rosenkranz S, Knirel D, Dietrich H, Flesch M, Erdmann E, Böhm M. Rosenkranz S, et al. FASEB J. 2002 Dec;16(14):1958-60. doi: 10.1096/fj.02-0207fje. Epub 2002 Oct 18. FASEB J. 2002. PMID: 12397093

3

Ritonavir exhibits anti-atherogenic properties on vascular smooth muscle cells.

Kappert K, Caglayan E, Bäumer AT, Südkamp M, Fätkenheuer G, Rosenkranz S. Kappert K, et al. Among authors: rosenkranz s. AIDS. 2004 Feb 20;18(3):403-11. doi: 10.1097/00002030-200402200-00005. AIDS. 2004. PMID: 15090791

4

TGF-beta1 and angiotensin networking in cardiac remodeling.

Rosenkranz S. Rosenkranz S. Cardiovasc Res. 2004 Aug 15;63(3):423-32. doi: 10.1016/j.cardiores.2004.04.030. Cardiovasc Res. 2004. PMID: 15276467 Review.

5

The Arg389Gly beta1-adrenoceptor gene polymorphism determines contractile response to catecholamines.

La Rosée K, Huntgeburth M, Rosenkranz S, Böhm M, Schnabel P. La Rosée K, et al. Among authors: rosenkranz s. Pharmacogenetics. 2004 Nov;14(11):711-6. doi: 10.1097/00008571-200411000-00001. Pharmacogenetics. 2004. PMID: 15564877

6

Systematic evaluation of anti-apoptotic growth factor signaling in vascular smooth muscle cells. Only phosphatidylinositol 3'-kinase is important.

Vantler M, Caglayan E, Zimmermann WH, Bäumer AT, Rosenkranz S. Vantler M, et al. Among authors: rosenkranz s. J Biol Chem. 2005 Apr 8;280(14):14168-76. doi: 10.1074/jbc.M413310200. Epub 2005 Jan 7. J Biol Chem. 2005. PMID: 15640155 Free article.

7

Alcohol consumption and hypertension.

Huntgeburth M, Ten Freyhaus H, Rosenkranz S. Huntgeburth M, et al. Among authors: rosenkranz s. Curr Hypertens Rep. 2005 Jun;7(3):180-5. doi: 10.1007/s11906-005-0007-2. Curr Hypertens Rep. 2005. PMID: 15913491 Review.

8

17Beta-estradiol attenuates PDGF signaling in vascular smooth muscle cells at the postreceptor level.

Kappert K, Caglayan E, Huntgeburth M, Bäumer AT, Sparwel J, Uebel M, Rosenkranz S. Kappert K, et al. Among authors: rosenkranz s. Am J Physiol Heart Circ Physiol. 2006 Feb;290(2):H538-46. doi: 10.1152/ajpheart.00240.2005. Epub 2005 Oct 14. Am J Physiol Heart Circ Physiol. 2006. PMID: 16227346 Free article.

9

Phosphodiesterase type 5 inhibition is a novel therapeutic option in Raynaud disease.

Caglayan E, Huntgeburth M, Karasch T, Weihrauch J, Hunzelmann N, Krieg T, Erdmann E, Rosenkranz S. Caglayan E, et al. Among authors: rosenkranz s. Arch Intern Med. 2006 Jan 23;166(2):231-3. doi: 10.1001/archinte.166.2.231. Arch Intern Med. 2006. PMID: 16432094 Clinical Trial.

10

Dysfunction of an atrial septal defect occluder 8 years after implantation.

Ten Freyhaus H, Rosenkranz S, Südkamp M, Höpp HW. Ten Freyhaus H, et al. Among authors: rosenkranz s. J Interv Cardiol. 2006 Apr;19(2):163-5. doi: 10.1111/j.1540-8183.2006.00124.x. J Interv Cardiol. 2006. PMID: 16650246 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

655 results

Search Page

Filters